|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-15
|
|
pubmed:abstractText |
The U3271C mutation affecting the human mitochondrial transfer RNA(Leu(UUR)) (hs mt tRNA) is correlated with diabetes and mitochondrial encephalopathies. We have explored the relationship between the structural effects of this mutation and its impact on function using chemical probing experiments and in vitro aminoacylation assays to investigate a series of tRNA constructs. Chemical probing experiments indicate that the U3271C substitution, which replaces an AU pair with a CA mispair, significantly destabilizes the anticodon stem. The introduction of a compensatory A3261G mutation reintroduces base pairing at this site and restores the structure of this domain. In fact, the anticodon stem of the A3261G/U3271C mutant appears more structured than wild-type (WT) hs mt tRNA(Leu(UUR)), indicating that the entirely AU stem of the native tRNA is intrinsically weak. The results of the chemical probing experiments are mirrored in the aminoacylation activities of the mutants. The U3271C substitution decreases aminoacylation reactivity relative to the WT tRNA due to an increase in K(m) for the pathogenic mutant. The binding defect is a direct result of the structural disruption caused by the pathogenic mutation, as the introduction of the stabilizing compensatory mutation restores aminoacylation activity. Other examples of functional defects associated with the disruption of weak domains in hs mt tRNAs have been reported, indicating that the effects of pathogenic mutations may be amplified by the fragile structures that are characteristic of this class of tRNAs.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-10066735,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-10076021,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-10660592,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-10684970,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-10858457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-11000270,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-11017193,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-11073213,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-11110797,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-11532943,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-11691920,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-12000830,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-12101407,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-1329109,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-1932147,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-377283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-6159633,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-7219534,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-8114089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-9399820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-9455930,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-9466989,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-9512533,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-9744809,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12527767-9889270
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1362-4962
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
596-601
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12527767-Anticodon,
pubmed-meshheading:12527767-Base Sequence,
pubmed-meshheading:12527767-DNA, Mitochondrial,
pubmed-meshheading:12527767-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:12527767-Humans,
pubmed-meshheading:12527767-Kinetics,
pubmed-meshheading:12527767-Leucine-tRNA Ligase,
pubmed-meshheading:12527767-Molecular Sequence Data,
pubmed-meshheading:12527767-Nucleic Acid Conformation,
pubmed-meshheading:12527767-Point Mutation,
pubmed-meshheading:12527767-RNA, Transfer, Amino Acyl,
pubmed-meshheading:12527767-RNA, Transfer, Leu,
pubmed-meshheading:12527767-Sequence Homology, Nucleic Acid
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The pathogenic U3271C human mitochondrial tRNA(Leu(UUR)) mutation disrupts a fragile anticodon stem.
|
|
pubmed:affiliation |
Department of Chemistry, Boston College, Merkert Chemistry Center, Chestnut Hill, MA 02467, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
